A 50 year-old woman with iron deficiency anemia, renal failure and colitis: case report and brief review of literature

Roxana Maxim, Emanuela Sarca, Alexandra Chelaru, Alina Pleșa


The hemolytic uremic syndrome (HUS) is defined by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure. The typical presentation of HUS occurs following a diarrheal prodrome. Diarrhea is infectious, usually due to Shiga toxin-producing Escherichia coli. In typical HUS, the history may include exposure to contaminated food. Symptoms develop 24 hours to 8 days following ingestion of the offending agent. Atypical HUS (aHUS) is being described in a growing body of literature and is more commonly associated with neurologic impairment. Central nervous system involvement may occur in almost half of patients and symptoms vary from mild (lethargy, irritability) to severe (seizures, paresis, coma). Atypical HUS may be caused by a variety of etiologies, each with a different trigger resulting in the final common pathway of inflammatory cascade causing renal endothelial and vascular injury and resultant thrombotic microangiopathy. This report describes the case of a 50-year-old female who developed HUS.


hemolytic uremic syndrome, hemolytic anemia, iron deficiency, colitis

Full Text:



Sellier-Leclerc AL, Fremeaux-Bacchi V, Macher MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007; 18:2392-2400.

Kavanagh D, Raman S, Sheerin NS. Management of hemolytic uremic syndrome. F1000Prime Rep 2014; 6:119.

Mohlin FC, Nilsson SC, Levart TK, et al. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients. Mol Immunol 2015; 65(2):367-376.

Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008; 23(11):1951-1956.

Fakhouri F, Frémeaux-Bacchi V, Loirat C. Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy. Eur J Int Med 2013; 24(6):492-495.

Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial a HUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5(10):1844-1859.

Sullivan M, Erlic Z, Hoffmann MM, et al. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Ann Hum Genet 2010; 74(1):17-26.

Thorpe CM. Shiga toxin-producing Escherichia coli infection. Clin Infect Dis 2004; 38(9):1298-1303.

Walker WA. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 4th Edition. Hamilton, Ont.: BC Decker, 2004.

DOI: http://dx.doi.org/10.22551/2015.05.0201.10030

Copyright (c) 2015 Archive of Clinical Cases

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975